Product News and Recalls

Mealey’s Pharmaceutical Litigation SuperConference

Mealey’s™ Pharmaceutical

Litigation SuperConference

A Plaintiff’s Bar Discussion

June 23 -25, 2008 • Embassy Suites Chicago – Downtown / Lakefront, Chicago

Chair:

Ramon Lopez, Esq., Lopez McHugh, LLP, Newport Beach, CA

Agenda and Networking Events

Monday, June 23, 2008

8:00 Registration & Continental Breakfast

9:00 Welcome & Introductory Remarks

Ramon Lopez, Esq., Lopez McHugh, LLP, Newport Beach, CA

9:15 Bextra® Litigation

• Litigation update

• Latest studies and reports

• MDL — individual, medical monitoring and third-party complaints

• Future of the ...

continue reading...

CellCept and Myfortic injuring children and adults

On 5/16/2008 the FDA issued an alert for users of the immunosuppresants Mycophenolate Mofetil (marketed as CellCept) and Mycophenolic Acid (marketed as Myfortic). These drugs are commonly prescribed after organ transplants to prevent organ rejection, and have also been prescribed for immunemediated conditions such as systemic lupus erythematosus (SLE) and erythema multiforme.

Children Born With Birth Defects

These medications have led to reports of infants born with serious birth defects, including microtia (deformity of the outer ear) and cleft lip and palate. ...

continue reading...

CellCept and Myfortic injuring children and adults

On 5/16/2008 the FDA issued an alert for users of the immunosuppresants Mycophenolate Mofetil (marketed as CellCept) and Mycophenolic Acid (marketed as Myfortic). These drugs are commonly prescribed after organ transplants to prevent organ rejection, and have also been prescribed for immunemediated conditions such as systemic lupus erythematosus (SLE) and erythema multiforme.

CHILDREN BORN WITH BIRTH DEFECTS

These medications have led to reports of infants born with serious birth defects, including microtia (deformity of the outer ear) and cleft lip and palate. ...

continue reading...

Dennis Quaid Sheds Light On Avoidable Medical Errors and FDA Attempts to Shield Pharmaceutical Companies From Liability

May 14, 2008 – Actor Dennis Quaid testified before the Congressional Committee on Oversight and Government Reform in a hearing entitled, “Should FDA Drug and Medical Device Regulation Bar State Liability Claims?” The issue was whether FDA approval of a drug or medical device should prevent private persons from suing the manufacturers of those drugs or devices, a doctrine called “preemption.” Other notable testimony against preemption came from New England Journal of Medicine editor Gregory Curfman and former ...

continue reading...

IRAQ WAR CONTRACTOR LITIGATION

LAWSUITS OVER HALLIBURTON TRUCKER DEATHS
MAY GO TO TRIAL IN 2009

by Jenny Albano

Thursday, July 24, 2008

Click here to go to external article

After being dismissed in 2006, lawsuits against military contractors Halliburton and Kellogg Brown & Root (KBR), a former subsidiary, may go to trial in 2009. The lawsuits are over an ambush that left six civilian truck drivers in Iraq dead.

The lawsuits filed by the deceased truck drivers families claim that the companies knowingly sent convoys into a dangerous ...

continue reading...

Digitek Recall

Digitek, a generic form of digoxin or lanoxin, also known as digitalis, is a medication used for treating heart problems such as congestive heart failure and abnormal heart rhythm such as atrial fibrillation or flutter. It is manufactured by Actavis Totowa and distributed by two companies connected to Actavis: Mylan Pharmaceuticals, Inc. using the “Bertek” label and UDL Laboratories, Inc. using the “UDL” label.

On April 25, 2008, Actavis issued a recall of Digitek because some tablets have been manufactured ...

continue reading...
Page 297 of 299 «...270280290295296297298299